cancer ppt 2008
TRANSCRIPT
Cancer
Introduction A group of more than 200 diseases
characterized by uncontrolled and unregulated growth of cells
In NZ 14,808 new cases of cancer 1 in 3 men and 1 in 4 women will be
affected by age 75yrs Most common cause of death in NZ (29%
of deaths overall)
Cancer
Most common cancers causing death in males are lung, prostate and colorectal
Most common cancers causing death in females are breast, lung & colorectal
Cancer rates for Maori & non Maori are similar but mortality rates are 51% (males) and 78%(females) higher for Maori
5-year survival rate is now 62% for those who are disease free, in remission, or under treatment
5-year survival rates do not include the number of people who are “cured” of cancer
Defect in Cellular Proliferation (process by which cells divide & reproduce)
Cancer cells are characterized by the loss of contact inhibition – have no regard for cellular boundaries Grow on top of one another and on top of or
between normal cells Cancer cells divide indiscriminately and
haphazardly – sometimes they produce more than 2 cells at the time of mitosis
Defect in Cell Proliferation
In most situations, cancer cells multiply at the same rate as the normal cells from which they originate
The difference is that proliferation of the cancer cells is indiscriminate and continuous
Because of this there is continuous growth of a tumour mass
Defect in Cellular Differentiation
Cellular differentiation (the development of specific & distinctive features in cells) is normally an orderly process
Protooncogenes- Normal cellular genes that are important
regulators on normal cellular processes- Mutations that alter their expression can
activate them to act as oncogenes (tumour-inducing)
Neoplasms
Characterised as:
1. Benign neoplasms
2. Malignant neoplasms
Major difference between malignant & benign neoplasms is the ability of malignant tumour cells to invade and metastasize
Benign Neoplasms
Well differentiated (specific & distinctive features of cells are well developed).
Cells resemble the cells of tissue of origin. Well-defined fibrous capsule Characterized by slow, progressive rate of growth. Tumours grow by expansion Metastases absent Recurrence unusual Do not usually cause death unless they interfere with vital
functions because of location e.g.. Benign cranial tumour compressing brain structures
Malignant Neoplasms
Tend to grow rapidly, spread widely, & kill regardless of original location
Able to metastasize Because of rapid growth, they compress blood vessels & outgrow
their blood supply causing ischaemia & tissue necrosis Rob normal tissues of essential nutrients Liberate enzymes & toxins that destroy normal & tumour tissue Infiltrative and expansive Frequent recurrence Moderate to marked vascularity Rarely encapsulated Cells abnormal; become more unlike parent cells
Effects on Body Function with Cancer Growth
Altered function of involved tissue Bleeding & haemorrhage Ulceration, necrosis & infection of tumour area Obstruction of hollow organs or pathways Effusion in serous cavities Increased risk of vascular thrombosis Anaemia Bone destruction
Effects (cont.)
Hypercalcaemia Pain Cachexia – weight loss & wasting of body fat
& lean protein Inappropriate hormone production (e.g. ADH
or ACTH secretion by cancers such as bronchogenic carcinaoma)
Cachexia
Advanced Breast Cancer
Cancer of Kidney
Ascites – Liver Cancer
Development of Cancer
Carcinogens – cancer-causing agents capable of producing cellular alterations
Can be chemical, environmental, immunologic, viral, or spontaneous in origin
Some genetic abnormalities increase the susceptibility of individuals to certain cancers
Hereditary predisposition in approx 50 types of cancers e.g. breast cancer
Process of Cancer Development
Fig. 15-3
Metastasis
The spread of cancer from the initial or primary site to a distant site
Some metastasize early e.g. pre-menopausal breast cancer
Others spread regionally and rarely metastasize e.g.. BCC of skin
Certain cancers have an affinity for a particular tissue or organ as a site of metastasis, others are unpredictable e.g. melanoma
Metastasis (cont.)
Certain cancers (‘seed’), such as ovarian cancer, require a particular site for proliferation (‘soil’)
Most frequent sites for metastases are lungs, brain, , bone, liver & adrenals
Metastasis
Metastasis process begins with rapid growth of primary tumour Development of its own blood
supply is critical for survival Tumour angiogenesis is
formation of blood vessels within the tumour
Melanoma Metastases
Progression of Cancer Metatases
Role of Immune System
Immune response is to reject or destroy cancer cells if perceived as non-self May be inadequate as cancer cells arise
from normal human cells Some cancer cells have changes on their
surface antigens Tumor-associated antigens (TAAs)
Role of Immune System
Response to TAAs is termed immunologic surveillanceLymphocytes continually check cell
surfaces and detect and destroy cells with abnormalities
Involves cytotoxic T cell, natural killer cells, macrophages, and B lymphocytes
Role of Immune System
Escape mechanisms by which cancer cells evade immune systemSuppression of factors that
stimulate T cellsWeak surface antigens allow cancer
cells to “sneak through” surveillance
Role of Immune System
Development of tolerance of immune system
Suppression of immune response to products secreted by cancer cells
Induction of suppressor T cells Blocking antibodies that bind TAAs
Classification of Cancer
Anatomic Site ClassificationIdentified by
tissue originanatomic sitebehaviour of the tumour
Classification of Cancer
Anatomic Site ClassificationCarcinomas originate from
embryonal ectoderm and endodermSarcomas originate from embryonic
mesodermLymphomas and leukaemias
originate from hepatopoietic system
Classification of Cancer
Histologic Analysis ClassificationAppearance of cells and degree of
differentiation are evaluatedGrade 1: Cells differ slightly from
normal cells and are well differentiated
Grade 2: Cells more abnormal and moderately differentiated
Classification of Cancer
Grade 3: Cells very abnormal and poorly differentiated
Grade 4: Cells immature and primitive and undifferentiated; cell of origin difficult to determine
Classification of Cancer
Clinical Staging 0: cancer in situ 1: tumor limited to tissue of origin 2: limited local spread 3: extensive local and regional spread 4: metastasis
Classification of Cancer
TNM ClassificationTumor sizeSpread to lymph nodesMetastasis
TNM Classification System
T (tumour)
Tx Tumour unable to be adequately assessed
T0 No evidence of primary tumour
Tis Carcinoma in situ
T1-4 Progressive increase in tumour size or involvement
TNM Classification System
N (nodes)
Nx Regional lymph nodes cannot be assessed
N0 No evidence of regional node metastasis
N1-3 Increasing involvement of regional lymph nodes
TNM Classification System
M (metastasis)
Mx Not assessed
M0 No distant metastasis
M1 Distant metastasis present, specify sites
Prevention and Detection of Cancer
Reduce or avoid exposure to known or suspected carcinogens
Eat balanced diet Exercise regularly Adequate rest Health examination on a regular basis
Prevention and Detection of Cancer
Eliminate, reduce, or change perceptions of stressors and enhance ability to cope
Enjoy consistent periods of relaxation and leisure
Know 7 warning signs of cancer Self-examination Seek medical care if cancer is suspected
Early Warning Signs of Cancer
Change in bowel or bladder habits A sore that does not heal Unusual bleeding or discharge Thickening or lump in breast or elsewhere Indigestion or difficulty in swallowing Obvious change in mole or wart Nagging cough or hoarseness